Prevalence of atrial fibrillation and the HATCH score: Intensified monitoring of patients with high HATCH score;Prävalenz von Vorhofflimmern und der HATCH-Score: Intensiviertes Monitoring bei Patienten mit hohem HATCH-Score

Herz

Volumn 40, Issue 5, 2015, Pages 803-808

  Tischer, Tina S ^a   Schneider, Ralph ^a   Lauschke, Jörg ^a   Diedrich, Doreen ^b   Kundt, Günther ^b   Bänsch, Dietmar ^a  

^a Heart Center Rostock   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Atrial fibrillation; HATCH score; Prevalence; Prevention; Stroke

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX RATIO; VERY ELDERLY; COMORBIDITY; GERMANY; INCIDENCE; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE;

AGED; ATRIAL FIBRILLATION; CAUSALITY; COMORBIDITY; DISEASE PROGRESSION; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84939264284     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-015-4305-4     Document Type: Article

References (24)

1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation–developed with the special contribution of the European Heart Rhythm Association. Europace 14(10):1385–1413. doi:10.1093/europace/eus305
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980–2000, and implications on the projections for future prevalence. Circulation 114(2):119–125. doi:10.1161/CIRCULATIONAHA.105.595140
3. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, DʼAgostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110(9):1042–1046. doi:10.1161/01.CIR.0000140263.20897.42
4. Kirchhof P, Breithardt G, Aliot E, Khatib SA, Apostolakis S, Auricchio A, Bailleul C, Bax J, Benninger G, Blomstrom-Lundqvist C, Boersma L, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Casadei B, Clemens A, Crijns H, Derwand R, Dobrev D, Ezekowitz M, Fetsch T, Gerth A, Gillis A, Gulizia M, Hack G, Haegeli L, Hatem S, Georg Hausler K, Heidbuchel H, Hernandez-Brichis J, Jais P, Kappenberger L, Kautzner J, Kim S, Kuck KH, Lane D, Leute A, Lewalter T, Meyer R, Mont L, Moses G, Mueller M, Munzel F, Nabauer M, Nielsen JC, Oeff M, Oto A, Pieske B, Pisters R, Potpara T, Rasmussen L, Ravens U, Reiffel J, Richard-Lordereau I, Schafer H, Schotten U, Stegink W, Stein K, Steinbeck G, Szumowski L, Tavazzi L, Themistoclakis S, Thomitzek K, Van Gelder IC, von Stritzky B, Vincent A, Werring D, Willems S, Lip GY, Camm AJ (2013) Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace 15:1540–1556. doi:10.1093/europace/eut232
5. Benjamin EJ, Wolf PA, DʼAgostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98(10):946–952
6. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429. doi:10.1093/eurheartj/ehq278
7. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (2006) ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(7):e257–354. doi:10.1161/CIRCULATIONAHA.106.177292
8. Thrall G, Lip GY, Carroll D, Lane D (2007) Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest 132 (4):1259–1264. doi:10.1378/chest.07-0036
9. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120–129. doi:10.1056/NEJMoa1105575
10. Zuo ML, Liu S, Chan KH, Lau KK, Chong BH, Lam KF, Chan YH, Lau YF, Lip GY, Lau CP, Tse HF, Siu CW (2013) The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke. J Interv Card Electrophysiol 37(1):47–54. doi:10.1007/s10840-012-9776-0
11. Camm AJ, Corbucci G, Padeletti L (2012) Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol 110(2):270–276. doi:10.1016/j.amjcard.2012.03.021
12. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, DʼAgostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ (2009) Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 373(9665):739–745. doi:10.1016/S0140-6736(09)60443-8
13. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kaab S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ (2013) Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2(2):e000102. doi:10.1161/JAHA.112.000102
14. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ (2010) Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 55(8):725–731. doi:10.1016/j.jacc.2009.11.040
15. Rho RW, Page RL (2005) Asymptomatic atrial fibrillation. Prog Cardiovasc Dis 48(2):79–87. doi:10.1016/j.pcad.2005.06.005
16. Heeringa J (2010) Atrial fibrillation: is the prevalence rising? Europace 12(4):451–452. doi:10.1093/europace/euq056
17. Mullenix PS, Martin MJ, Steele SR, Lavenson GS Jr, Starnes BW, Hadro NC, Peterson RP, Andersen CA (2006) Rapid high-volume population screening for three major risk factors of future stroke: phase I results. Vasc Endovascular Surg 40(3):177–187
18. Patel KP (1977) Electrocardiographic abnormalities in the sick elderly. Age Ageing 6(3):163–167
19. Friberg L, Engdahl J, Frykman V, Svennberg E, Levin LA, Rosenqvist M (2013) Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). Europace 15(1):135–140. doi:10.1093/europace/eus217
20. Ziegler PD, Glotzer TV, Daoud EG, Singer DE, Ezekowitz MD, Hoyt RH, Koehler JL, Coles J Jr, Wyse DG (2012) Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. Am J Cardiol 110(9):1309–1314. doi:10.1016/j.amjcard.2012.06.034
21. Stroke Risk in Atrial Fibrillation Working Group (2007) Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 69(6):546–554. doi:10.1212/01.wnl.0000267275.68538.8d
22. Friberg L, Rosenqvist M, Lip GY (2012) Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 33(12):1500–1510. doi:10.1093/eurheartj/ehr488
23. Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY (2012) Reliable identification of “truly low” thromboembolic risk in patients initially diagnosed with “lone” atrial fibrillation: the Belgrade atrial fibrillation study. Circ Arrhythm Electrophysiol 5(2):319–326. doi:10.1161/CIRCEP.111.966713
24. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY (2012) The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: a nationwide cohort study. Thromb Haemost 107(6):1172–1179. doi:10.1160/TH12-03-0175